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Oxidative stress plays critical roles in the pathogenesis of diabetes, hypertension, and atherosclerosis;
some authors reported that fat accumulation correlates to systemic oxidative stress in human and mice,
but cellular redox environment effect on lipid accumulation is still unclear. In our laboratory we used
mouse embryonic ﬁbroblasts (undifferentiated cells: CC), which are capable of differentiating into ma-
ture adipocytes (differentiated cells: DC) and accumulate lipids, as obesity model. Here we analyzed the
role of the well-known antioxidant and glutathione precursor N-acetylcysteine (NAC) in cellular MAPK
modulation and lipid accumulation. We evaluated the effect of NAC on the adipogenic differentiation
pathway using different doses: 0.01, 0.1, 1 and 5 mM; no toxic doses in these cells. A dose of 5 mM NAC
[DCN-5] provoked a signiﬁcant decrease in triglyceride accumulation (72710 [DCN-5] vs 169715 [DC],
po0.01), as well in Oil Red O stained neutral lipid content (12072 [DCN-5] vs 139712 [DC], po0.01).
Molecular mechanisms responsible for adipogenic differentiation involve increase of the expression of
phosphoERK½ and phosphoJNK, 5 mM NAC treatment inhibited both pERK½ and pJNK protein levels. We
also evaluated the mitotic clonal expansion (MCE) which takes place during adipogenesis and observed
an increase in DC at a rate of 1.5 cells number compared to CC at day 2, whereas the highest doses of NAC
signiﬁcantly inhibited MCE. Our results suggest that NAC inhibits lipid accumulation and the MAPK
phosphorylation in mouse embryonic ﬁbroblasts during adipogenic differentiation and further con-
tribute to probe the importance of cellular redox environment in adipogenesis.
& 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Research investigating redox regulation has received a large
amount of attention due to the role of oxidative stress in several
diseases. Excessive production of reactive oxygen species (ROS)
induces oxidative stress in cells, but non-toxic levels of ROS
have been described in relation to intracellular signal trans-
duction, thereby regulating fundamental cell behaviors such as
proliferation and differentiation [1]. However, ROS have a very
short half-life, and their cellular levels are very difﬁcult to re-
produce. Therefore, the effect of ROS can be difﬁcult to measure.
An alternative strategy to achieve this goal is to evaluate the
effects of antioxidants in a systemic study. New adipocytes
could develop from precursor such 3T3-L1 ﬁbroblasts or mouse
embryonic ﬁbroblasts (MEF). We have previously shown
that antioxidant N-acetylcysteine (NAC) inhibits adipogenicB.V. This is an open access article udifferentiation in the 3T3-L1 cell line [2,3]. Here, we explored
this antioxidant effects on primary cultures from MEF because
3T3-L1 are committed cells.
The molecular mechanisms that are responsible for the adi-
pogenic differentiation involve regulation of the expression of
MAPKs (Mitogen-Activated Protein Kinases) such as phospho-ERK
(p ERK½) and phospho-JNK (pJNK). This regulation leads to
terminal differentiation and accumulation of triglycerides (Tg) in
the adipocytes and as a consequence, the potential to develop
obesity [4,5]. As for the role of ERK½ in differentiation process, it is
involved in an initial proliferation called mitotic clonal expansion
(MCE) that takes place during the two ﬁrst days of adipogenesis
[6]. The signaling pathways that involve JNK are strongly re-
sponsive to redox regulation. Thus, an exploration of the molecular
regulation of ERK½ and JNK MAPKs during adipogenesis is im-
portant for understanding cellular differentiation. Of particular
interest is the modulation that occurs during an antioxidant
treatment that inhibits the accumulation of triglycerides, which
would be the ﬁnal event in the differentiation of preadipocytes.
Questions such as “how does the activation of mitogen-activated
protein kinase (MAPK) modules in response to differentnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. MEF at day 10 of differentiation. (A) Control cells (CC); (B) MDI-treated cells (DC). Lipid droplets are shown in black. Representative results from one of three
experiments with similar results are shown.
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[7] could be answered using this strategy.
The use of NAC as a regulator of the adipogenic process is under
discussion [2,3,8,9]. In the present study, our aim is to evaluate the
relationship between the accumulation of lipids and MAPK during
MEF cellular differentiation through treatment with the anti-
oxidant NAC.2. Materials and methods
2.1. Isolation of mouse embryonic ﬁbroblasts (MEF)
Mouse embryonic ﬁbroblasts (MEFs) were prepared from CF-1
mouse embryos at day 14 of gestation, by culture of small tissue
explants as previously described [10]. Brieﬂy, the embryos were
removed from the uterus and washed with PBS. Once the head and
red organs were dissected, the embryonic tissue was washed with
PBS and ﬁnely minced using a sterile razor blade until the tissue
could be handled with a pipette. After that, trypsin-EDTA was
added and the sample was incubated for 30 min at 37 °C. Trypsin
was inactivated by adding Dulbecco's Modiﬁed Eagle's Medium
(DMEM) supplemented with 25 mM glucose and 10% fetal bovine
serum (FBS). Cells were centrifuged at 300 g for 5 min; the pellet
was plated in culture bottles with complete media (DMEM plus
25 mM glucose and 10% FBS). The outgrowing primary cell popu-
lation was passaged by trypsinization at ratio of 1:3 upon con-
ﬂuency and continuously cultured in complete media to favor
growth of ﬁbroblastic cells.
2.2. MEF adipocyte differentiation
MEF were ﬁrst cultured in MDI medium (0.5 mM 3-isobutyl-1-
methyl xanthine, 0.1 μM dexamethasone, and 2 μM insulin) for
72 h. They were then transferred to fresh DMEM (25 mM glucose;
10% FBS) supplemented with 2 μM insulin and incubated for three
days. The cells were then cultured in fresh complete media for the
remainder of the experiment. Day 0 of differentiation was deﬁned
as the time at which the cells were ﬁrst introduced to MDI med-
ium. At day 10, 70–80% of cells dramatically increased their tri-
glyceride (Tg) content, thereby generating refractive droplets that
were easily observed by microscopy or Oil Red O staining. MDI-
treated MEF were considered differentiating cells (DC), and
vehicle-treated MEF were considered control cells (CC).NAC was added to the MDI medium at day 0 of differentiation
and maintained in the medium throughout the remainder of the
experiment; these cells were considered NAC-treated differ-
entiating cells (DCN).
2.3. Oil Red O staining
Cell monolayers were washed three times with PBS and then
ﬁxed with 4% formaldehyde in PBS, at 4 °C for 30 min. A stock
solution of 0.4% Oil Red O (SIGMA) in isopropanol was prepared. To
perform the assay, the dye was diluted with water, ﬁltered and
added to the ﬁxed cells. Oil Red O staining was developed at room
temperature for 30 min. Cells were then washed with water and,
the stained lipids droplets in the cells were visualized and pho-
tographed. After that, the dye was extracted with isopropanol and
its absorbance was determined at 510 nm to quantify the staining
lipids.
2.4. Determination of triglyceride and protein levels
Tg accumulation was assessed using a TG color GPO/PAP AA kit
(Wiener Laboratory, Rosario, Argentina). Proteins were quantiﬁed
by the Bradford method using crystalline bovine serum albumin as
standard [11].
2.5. MTT assay
To evaluate the toxicity of NAC treatment, MTT (Bromide 3-
(4,5-dimethylthiazol-2-yl)-2,5-difeniltetrazol) viability assay was
performed [12]. The technique is based on the presence of mi-
tochondrial enzymes in viable cells that reduce the MTT dye and
produce a color purple. A stock solution of 5 mg/mL MTT was
prepared. To perform the assay, the dye was diluted in complete
media to a working concentration of 1 mg/mL. Cells were seeded
at 20104 cells/well and 300 μL of MTT were added to each well.
After incubation for 1 h, the medium was removed and the cells
were treated with 200 μL of ethanol for 10 min. The resulting
solution in each well was transferred to an ELISA plate and its
absorbance was measured at 550 nm. To further evaluate toxicity,
we performed assays in which cell viability was determined under
different concentrations of NAC including 0.01 mM, 0.1 mM, 1 mM
and 5 mM. The absorbance of control cells (CC) was set to 100%
and the results are presented as percentages of CC.
Fig. 2. NAC effect on triglyceride (Tg) accumulation in MEF at day 10 of differ-
entiation. MDI cells were treated with 0.01 mM NAC (DCN-0.01), 0.1 mM NAC
(DCN-0.1), 1 mM NAC (DCN-1) or 5 mM NAC (DCN-5). NAC was added at day 0 and
replaced every day for 10 days. Control cells (CC), MDI-treated cells (DC) and MDI–
NAC-treated cells were harvested at day 10 and, Tg determinations were per-
formed. Cellular Tg content was normalized by cellular protein content. Tg content
of control cells (CC) was set to 100, data represent the percentage of CC. The results
are the average of four independent experiments (mean7SD). *po0.01: control
cells (CC) vs MDI-treated cells (DC); *po0.01: MDI – 5 mM NAC-treated cells (DCN-
5) vs MDI-treated cells (DC).
Fig. 3. NAC effect on neutral lipid accumulation visualized with Oil Red O in MEF at
day 10 of differentiation. MDI cells were treated with 0.01 mM NAC (DCN-0.01),
0.1 mM NAC (DCN-0.1), 1 mM NAC (DCN-1) or 5 mM NAC (DCN-5). NAC was added
at day 0 and replaced every day for 10 days. Control cells (CC), MDI-treated cells
(DC) and MDI–NAC-treated cells were harvested at day 10 and Oil Red O dye was
extracted and determined. Cellular lipid content was normalized by cell number.
Lipid content of control cells (CC) was set to 100, data represent the percentage of
CC. The results are the average of four independent experiments (mean7SD).
*po0.01: control cells (CC) vs MDI-treated cells (DC); *po0.01: MDI – 5 mM NAC
treated cells (DCN-5) vs MDI-treated cells (DC).
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Cells (50104) were seeded on a plate and cultured in the
presence of vehicle or NAC (0.01 mM, 0.1 mM, 1 mM or 5 mM). The
cells were counted at the indicated times. Viable cells were dis-
criminated by trypan blue stain exclusion. Cell number of control
cells (CC) was set to 1 and the results are presented as percentages
of CC.2.7. Western blots
Brieﬂy, the experiment was carried out by culturing MEF in
medium with 0.5% FBS for one hour to reduce basal levels of
phosphorylation; subsequently, different doses of NAC were in-
cluded in the MDI medium, and the cells were harvested after
30 min of treatment. After the treatment, the cells were lysed with
a buffer containing 1% SDS in 60 mM Tris–HCl, boiled for 10 min
and, centrifuged at 15,000 rpm at 4 °C for 10 min. Then the sam-
ples were resuspended in buffer supplemented with protease in-
hibitor mixture (Thermo Protease Inhibitor Cocktail). Proteins
(40 μg from each sample) were then separated on 10% SDS-poly-
acrylamide gels and then transferred to nitrocellulose membranes
(Amersham; GE Healthcare, Little Chalfont, UK). The primary an-
tibodies were anti-JNK, anti-pJNK, anti-ERK½ and anti-pERK½
(Santa Cruz Biotechnology). The membranes were soaked in
blocking buffer (0.1% BSA, 0.4% Tween, and 1 mM EDTA in 0.01 M
PBS) for 1 h, incubated overnight with primary antibody at 4 °C. To
detect the western blot signal, membranes were probed with
horseradish-conjugated secondary antibodies (Santa Cruz Bio-
technology, Santa Cruz, Ca, USA), and then treated with an en-
hanced chemiluminescence (ECL) substrate kit (Amersham ECL
Plus Western Blotting Detection System, GE Healthcare). Results
are expressed as arbitrary units.2.8. Statistics
The results are expressed as the mean7standard deviation
(SD). Statistical analysis was performed by one-way analysis of
variance followed by post hoc analysis [13]. The results represent
the average of four independent experiments (mean7SD). The
results were considered statistically signiﬁcant at po0.01.3. Results
We have previously evaluated the effect of NAC on triglyceride
accumulation in 3T3-L1 adipocytes. We demonstrated that 0.01 mM
NAC provides effective inhibition of adipocyte differentiation by in-
hibiting expression of adipogenic transcription factors (PPARγ and C/
EBPβ), triglyceride accumulation and ap2 expression [3,4]. Here, we
decided to evaluate the effect of NAC on primary culture MEF, which
could differentiate after 10 days (Fig. 1). Fully differentiated cells (DC)
showed almost two times more Tg content than did the CC
(1.2270.11 g Tg/g protein [DC] vs. 0.7270.17 g Tg/g protein [CC],
po0.01). NAC was added to MDI medium at day 0 of the differ-
entiation protocol and replaced every day during all differentiation
experiments. Afterwards, we determined the Tg content and, four
different NAC doses (0.01 mM, 0.1 mM, 1 mM and 5 mM) were
evaluated. Only a signiﬁcant decrease in Tg accumulation was ob-
served with 5 mM NAC treatment (DCN-5) compared to DC (72710
[DCN-5] vs 169715 [DC], po0.01); DCN-5 showed a Tg content si-
milar to that observed in CC (Fig. 2). We also identiﬁed the Oil Red O
stained neutral lipids in MEF, allowing us to evaluate both trigly-
ceride and cholesteryl ester contents. Oil Red O stained neutral lipid
content was normalized by cell number of each treatment at day 10;
it is worth to mention that after day 2 of differentiation protocol the
cell number slightly change during the adipogenic differentiation. A
signiﬁcant decrease in DCN-5 was observed (12072 [DCN-5] vs
139712 [DC], po0.01), as shown in Figs. 3 and 4. None of the tested
NAC doses provoked toxic effects during cellular differentiation
(Fig. 5). Moreover, 5 mM NAC treatment did not produce any effects
on control cells (CCN), which showed a Tg content similar to that for
CC (0.7570.06 g Tg/g protein [CCN] vs 0.7270.17 g Tg/g protein[CC],
no signiﬁcant difference was observed).
Because MAPK phosphorylation took place in the adipocyte
differentiation pathway, we decided to evaluate the effect of
NAC on JNK and ERK phosphorylation. Indeed, an increase in
expression levels of pJNK and pERK½ in DC were observed. All
four doses of NAC (0.01 mM to 5 mM) decreased the levels of
pJNK almost 50% (Fig. 6A) without affecting JNK (pJNK/JNK:
0.9170.05 AU [DCN-5] vs 1.7670.05 AU [DC]). Likewise,
pERK½ expression was slightly inhibited at the highest doses
(1 m M and 5 mM) of NAC (Fig. 6(B)). Because ERK½ is involved
in cellular proliferation, we evaluated mitotic clonal expansion
(MCE) during MEF cellular differentiation. 50% increase in
cell number was found in DC compared to CC at 24 h of
Fig. 4. NAC effect on Oil Red O stained neutral lipid in MEF at day 10 of differentiation. Cells were stained with Oil Red O and photographed: (A) Control cells (CC); (B) MDI-
treated cells (DC); (C) MDI – 1 mM NAC-treated cells (DCN-1); (D) MDI – 5 mM NAC-treated cells (DCN-5). Stained lipid droplets are shown. Representative results from one
of four experiments with similar results are shown.
Fig. 5. Concentration-dependent effect of NAC on MEF viability. MDI cells were
treated with 0.01 mM NAC (DCN-0.01), 0.1 mM NAC (DCN-0.1), 1 mM NAC (DCN-1)
or 5 mM NAC (DCN-5). NAC was added at day 0 and replaced every day for 10 days.
Control cells (CC), MDI-treated cells (DC) and MDI–NAC-treated cells were har-
vested at day 10 and, MTT assays were performed. The absorbance of MDI-treated
cells (DC) was set to 100% of cell viability, data represent the percentage of CC. The
results shown are the averages of four independent experiments (mean7SD).
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served in CC thereafter (48 h: 7.5510570.11105 cells/mL
[CC] vs 11.7710570.16105 cells/mL [DC], po0.01). This
observation suggests that a limited mitotic cellular expansion
occurred. Only the highest doses of NAC (1 mM and 5 mM)
were inhibitory for MCE (48 h: 7.8710570.08105 cells/mL
[DCN-5] vs 11.7710570.16105 cells/mL [DC], po0.01), as
shown in Fig. 7.4. Discusion
The correlation between systemic oxidative stress and fat accumu-
lation, both in humans and in animals, has been shown. However,
changes in oxidative metabolism during differentiation from pre-
adipocytes to adipocytes differentiation have not been clearly explained.
The mechanism through which antioxidants may cause lipid accumu-
lation inhibition is still controversial [14,15]. The dose can be critical in
regard to inhibiting of inducing preadipocyte differentiation. Under-
standing adipocyte differentiation is relevant in terms of increasing our
knowledge of the pathogenesis of metabolic diseases, as well as in the
identiﬁcation of molecules or pathways that could be suitable target for
pharmacological intervention. In this context, we are interested in the
role of glutathione precursors, such as the NAC. Wang et al. [16] de-
monstrated that mice that consumed NAC decreased their body fat,
whereas Gou and collaborators [17] suggested that beta-mercapto-
ethanol (also precursor of glutathione as NAC), would increase ex-
pression of adipogenic genetic markers and accumulation of lipids. Due
to the controversial reports regarding the effect of glutathione pre-
cursors as antioxidants on lipid accumulation, their possible use in this
condition is still an open issue. In this way, we decided to evaluate JNK
signaling pathway, which is activated by oxidative cellular stress [18]
and phosphorylated during adipogenic differentiation [19,20]. We ob-
served an increase in expression levels of pJNK in DC; NAC treatments
produced an effective inhibition of pJNK expression, independent of
NAC doses. We did not evaluate ROS in MEF, but we suggest that an-
tioxidant environment could be responsible for decrease expression of
pJNK.
Fig. 6. Kinases phosphorylation in response to NAC treatment. (A) pJNK expression was evaluated; the results were normalized to JNK expression. (B) pERK½ expression was
evaluated; the results were normalized to ERK½ expression. Comparison of control cells (CC); MDI cells (DC) and MDI þ NAC treated cells (DCN-0.01: 0.01 mM NAC; DCN-
0.05: 0.05 mM NAC; DCN-1: 1 mM NAC; DCN-5: 5 mM NAC). The results are expressed as arbitrary units, arbitrary units of control cells (CC) was set to 1. The values represent
the fold increase in protein expression compared to control cells (CC). The bars show the average of two different experiments (means7SD). Representative results from one
of two independent western blot experiments with similar results are shown.
Fig. 7. NAC effect on MEF during mitotic clonal expansion (MCE). Comparison of control cells (CC); MDI cells (DC); MDI þ NAC treated cells (DCN). Cells were harvested at
day 1 (DC 24 h, DCN 24 h) or at day 2 (DC 48 h, DCN 48 h) of the differentiation protocol. The concentration of NAC is shown. Cells were counted and viable cells were
evaluated by trypan blue stain exclusion. Cell number of control cells (CC) was set to 1, data represent the percentage of CC. Results are the average of four different
experiments (mean7SD). *po0.01: MDI - 1 mM NAC-treated cells vs MDI-treated cells (DC); *po0.01: MDI – 5 mM NAC-treated cells vs MDI-treated cells (DC).
A. Pieralisi et al. / Redox Biology 9 (2016) 39–44 43In our laboratory we have studied some points that have not yet
been clariﬁed, such as GSH metabolism and the effect of anti-
oxidants on the adipogenic differentiation of the 3T3-L1 pre-
adipocytes. In our experience, NAC could inhibit triglyceride accu-
mulation during 3T3-L1 adipogenic differentiation, concomitant
with changes in GSH cellular content and through inhibition of
adipogenic transcription factor expression [3]. As a consequence, we
could temporarily relate the parameters of oxidative stress with
triglyceride production. We have also shown that NAC inhibited the
expression of some adipocyte proteins expression such as FABP4
(ap2), by almost 90% [4]. In this context, we decided to evaluate the
effect of NAC on MEF primary cultures. We showed for the ﬁrst time
that the highest dose of NAC effectively inhibited triglyceride ac-
cumulation in NAC-treated MEF adipocytes, but the antioxidant
slightly inhibited Oil Red O neutral lipid accumulation in the cells.
Meanwhile, none of the doses produced toxic effect on the cells.
Kinetic studies showed that NAC decreased the expression of
PPARγ by affecting CEBP/β expression without altering the phos-
phorylation of AKT [3]. Here, we observed that the highest doses of
NAC could decrease pERK½ expression, as well as inhibit MCE in MEF
cells during adipogenic differentiation. These results suggest the effectof NAC on lipid accumulation may be mediated, at least in part, by
affecting the activation of this kinase, as part of the MAPK pathway.Acknowledgements
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